Home/Filings/4/0001415889-23-003821
4//SEC Filing

Michael Robert A. 4

Accession 0001415889-23-003821

CIK 0001551152other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:30 PM ET

Size

4.4 KB

Accession

0001415889-23-003821

Insider Transaction Report

Form 4
Period: 2023-02-28
Michael Robert A.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Tax Payment

    Common Stock, $0.01 par value

    2023-02-28$154.28/sh48,335$7,457,12498,645 total

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001699914

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:30 PM ET
Size
4.4 KB